CLC Number:
| [1] Gokbuget N, Basara N, Baurmann H, et al. High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation [J]. Blood, 2011, 118(13):3504-3511. [2] 袁英,臧立,岳智杰,等. 74例淋巴母细胞淋巴瘤的临床特点及预后分析[J]. 肿瘤防治研究,2018,45(3):154-159. [3] Thomas DA, OBrien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma [J]. Blood,2004,104(6):1624-1630. [4] 中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会白血病淋巴瘤学组,中国临床肿瘤学会抗淋巴瘤联盟. 造血干细胞移植治疗淋巴瘤中国专家共识(2018版)[J].中华肿瘤杂志,2018,40(12):927-934. [5] Abaza Y, M Kantarjian H, Faderl S, et al. Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma[J]. Am J Hematol, 2018, 93(1): 91-99. [6] Song KW, Barnett MJ, Gascoyne RD, et al. Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes [J]. Ann Oncol, 2007, 18(3): 535-540. [7] Bersvendsen H, Kolstad A, Blystad AK, et al. Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma[J]. Acta Oncologica, 2014, 53(5):680. [8] Seong HJ, Joon HM, Seok KJ, et al. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation [J]. Ann Hematol,2015,94(4): 1-9. [9] Guan L, Li X, Wei H, et al. T cell-replete haploidentical peripheral blood hematopoietic cell transplantation for treatment of T-lymphoblastic lymphoma[J]. Ann Transplant, 2018,23: 427-433.doi: 10.12659/AOT.909122. [10] Hu M, Wang H, Wang L, et al. Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors,and performance of allogeneic hematopoietic stem cell transplantation[J]. Medicine(Baltimore), 2018, 97(28):11374. [11] Levine JE, Harris RE, Loberiza FR, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma [J]. Blood,2003,101(7): 2476-2482. [12] Chang YJ, Wang Y, Huang XJ, et al. Haploidentical stem cell transplantation for the treatment of leukemia: current status [J]. Expert Rev Hematol,2014,7(5): 635-647. [13] 张红宇, 黄晓军, 许兰平, 等. 异基因造血干细胞移植后出血性膀胱炎发生率及其危险因素分析[J]. 中华血液学杂志, 2007,28(4):243-246. [14] Cohen J, Gandhi M, Naik P, et al. Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning[J]. Br J Haematol, 2005, 129(2):229-239. |
| [1] | GUO Feng, HUANG Ning, GE Lin-Fu. Effects of allogeneic peripheral blood stem cell transplantation for severe aplastic anemia in childpatients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(12): 119-121. |
| [2] | . Differentiation and expansion of megakaryocytes from CD34+ cells derived from umbilical cord blood and change of gene expression [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(11): 95-99. |
|
||
